QA: RespireRx Pharmaceuticals Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000849636_2019_RespireRx_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000849636')"}

Graph

Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 121,076
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 3,114
4 LiabilitiesCurrent 5,857,445
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,488,238
9 ResearchAndDevelopmentExpense 688,286
10 remainder_Expenses 302,625
11 remainder_Revenues 0
12 remainder_NetIncome -112,641
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 124,190
1 Liabilities 5,857,445
2 Expenses 2,479,149
3 Revenues 0
4 StockholdersEquity -5,733,255
5 NetIncome -2,591,790
6 ComprehensiveNetIncome -2,591,790
7 BaseVar 4,286,712
8 EconomicCapitalRatio -4.16

Edgar->Model Mapping

Feature Distribution

Change over Time